University of Puerto Rico   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: San Juan Puerto Rico (1903)

Organization Overview

First Clinical Trial
1974
NCT00000491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Department of Orthopaedic Surgery, University of Puerto Rico, Medical Sciences Campus, San Juan, PR | Gamma Project - ACTU | Nutrition Program, School of Public Health, Medical Sciences Campus, University of Puerto Rico | Orthopaedic Surgery Section, University of Puerto Rico Medical Sciences Campus San Juan, Puerto Rico | School of Pharmacy, University of Puerto Rico | University of Puerto Rico | University of Puerto Rico Comprehensive Cancer Center | University of Puerto Rico Department of Obstetrics and Gynecology | University of Puerto Rico Medical Science Campus | University of Puerto Rico Orthopedics Department | University Puerto Rico San Juan PR (US) | Univ of Puerto Rico

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

AIDS Dementia Complex (Phase 3)

Cardiovascular Diseases (Phase 3)

Chikungunya Fever (Phase 2)

Communicable Diseases (Phase 3)

Coronary Disease (Phase 3)

Critical Illness (Phase 3)

Dementia (Phase 3)

Dengue (Phase 1)

Dentin Sensitivity (Phase 3)

Heart Diseases (Phase 3)

Hypersensitivity (Phase 3)

Ileus (Phase 4)

Infarction (Phase 3)

Infections (Phase 3)

Ischemia (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Osteoarthritis, Knee (Phase 4)

Osteoporosis (Phase 3)

Papillomavirus Infections (Phase 3)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 30